FDA inspection
Novartis Pharmaceutical Manufacturing GmbH: FDA inspection ending Jan 27, 2026
FDA inspection 1304780 · No Action Indicated (NAI) · Kundl
Key facts
| Inspection ID | 1304780 |
|---|---|
| Firm | Novartis Pharmaceutical Manufacturing GmbH |
| FEI number | 3027031635 |
| Address | Biochemiestrase 10 |
| City | Kundl |
| Country | Austria |
| Fiscal year | 2026 |
| Inspection end date | Jan 27, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data